Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Amanda Bartolini Silveira"'
Autor:
Lauren Darrigues, Jean-Yves Pierga, Alice Bernard-Tessier, Ivan Bièche, Amanda Bartolini Silveira, Marc Michel, Delphine Loirat, Paul Cottu, Luc Cabel, Coraline Dubot, Romain Geiss, Francesco Ricci, Anne Vincent-Salomon, Charlotte Proudhon, François-Clément Bidard
Publikováno v:
Breast Cancer Research, Vol 23, Iss 1, Pp 1-10 (2021)
Abstract Background Following the PALOMA-3 study results, the combination of palbociclib, a CDK4/6 inhibitor, with fulvestrant, a selective estrogen receptor degrader, has become a standard therapy in women with estrogen receptor-positive (ER+) HER2-
Externí odkaz:
https://doaj.org/article/89988fb8f03547508590ebccffb3a87d
Autor:
Marc Michel, Romain Geiss, Francesco Ricci, François-Clément Bidard, Luc Cabel, Paul Cottu, Charlotte Proudhon, Jean-Yves Pierga, Lauren Darrigues, Ivan Bièche, Anne Vincent-Salomon, Coraline Dubot, Amanda Bartolini Silveira, Alice Bernard-Tessier, Delphine Loirat
Publikováno v:
Breast Cancer Research, Vol 23, Iss 1, Pp 1-10 (2021)
Breast Cancer Research : BCR
Breast Cancer Research : BCR
Background Following the PALOMA-3 study results, the combination of palbociclib, a CDK4/6 inhibitor, with fulvestrant, a selective estrogen receptor degrader, has become a standard therapy in women with estrogen receptor-positive (ER+) HER2-negative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::199dfd6d14e359d45e37aa5ad4415a3d
https://doaj.org/article/89988fb8f03547508590ebccffb3a87d
https://doaj.org/article/89988fb8f03547508590ebccffb3a87d